Loading clinical trials...
Loading clinical trials...
This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alterity Therapeutics
NCT07644013 · Multiple System Atrophy, Parkinson's Disease, and more
NCT07197866 · Multiple System Atrophy
NCT06821256 · Multiple System Atrophy - Cerebellar Subtype (MSA-C)
NCT05748028 · Parkinson Disease, Multiple System Atrophy
NCT04246437 · Autonomic Failure, Pure Autonomic Failure, and more
University of California San Diego
La Jolla, California
Rush University Medical Center
Chicago, Illinois
Johns Hopkins University
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions